Literature DB >> 24797263

Proteomic analysis of the epidermal growth factor receptor (EGFR) interactome and post-translational modifications associated with receptor endocytosis in response to EGF and stress.

Jiefei Tong1, Paul Taylor1, Michael F Moran2.   

Abstract

Aberrant expression, activation, and stabilization of epidermal growth factor receptor (EGFR) are causally associated with several human cancers. Post-translational modifications and protein-protein interactions directly modulate the signaling and trafficking of the EGFR. Activated EGFR is internalized by endocytosis and then either recycled back to the cell surface or degraded in the lysosome. EGFR internalization and recycling also occur in response to stresses that activate p38 MAP kinase. Mass spectrometry was applied to comprehensively analyze the phosphorylation, ubiquitination, and protein-protein interactions of wild type and endocytosis-defective EGFR variants before and after internalization in response to EGF ligand and stress. Prior to internalization, EGF-stimulated EGFR accumulated ubiquitin at 7 K residues and phosphorylation at 7 Y sites and at S(1104). Following internalization, these modifications diminished and there was an accumulation of S/T phosphorylations. EGFR internalization and many but not all of the EGF-induced S/T phosphorylations were also stimulated by anisomycin-induced cell stress, which was not associated with receptor ubiquitination or elevated Y phosphorylation. EGFR protein interactions were dramatically modulated by ligand, internalization, and stress. In response to EGF, different E3 ubiquitin ligases became maximally associated with EGFR before (CBL, HUWE1, and UBR4) or after (ITCH) internalization, whereas CBLB was distinctively most highly EGFR associated following anisomycin treatment. Adaptin subunits of AP-1 and AP-2 clathrin adaptor complexes also became EGFR associated in response to EGF and anisomycin stress. Mutations preventing EGFR phosphorylation at Y(998) or in the S(1039) region abolished or greatly reduced EGFR interactions with AP-2 and AP-1, and impaired receptor trafficking. These results provide new insight into spatial, temporal, and mechanistic aspects of EGFR regulation.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24797263      PMCID: PMC4083106          DOI: 10.1074/mcp.M114.038596

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  64 in total

1.  The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling.

Authors:  E J Lowenstein; R J Daly; A G Batzer; W Li; B Margolis; R Lammers; A Ullrich; E Y Skolnik; D Bar-Sagi; J Schlessinger
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

2.  Cisplatin induces PKB/Akt activation and p38(MAPK) phosphorylation of the EGF receptor.

Authors:  S E Winograd-Katz; A Levitzki
Journal:  Oncogene       Date:  2006-06-19       Impact factor: 9.867

3.  Transient suppression of ligand-mediated activation of epidermal growth factor receptor by tumor necrosis factor-alpha through the TAK1-p38 signaling pathway.

Authors:  Pattama Singhirunnusorn; Yoko Ueno; Mitsuhiro Matsuo; Shunsuke Suzuki; Ikuo Saiki; Hiroaki Sakurai
Journal:  J Biol Chem       Date:  2007-02-27       Impact factor: 5.157

Review 4.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

5.  Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

Authors:  Jesper V Olsen; Blagoy Blagoev; Florian Gnad; Boris Macek; Chanchal Kumar; Peter Mortensen; Matthias Mann
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

6.  Endocytic trafficking of activated EGFR is AP-2 dependent and occurs through preformed clathrin spots.

Authors:  Joshua Z Rappoport; Sanford M Simon
Journal:  J Cell Sci       Date:  2009-04-07       Impact factor: 5.285

7.  A strategy for modulation of enzymes in the ubiquitin system.

Authors:  Andreas Ernst; George Avvakumov; Jiefei Tong; Yihui Fan; Yanling Zhao; Philipp Alberts; Avinash Persaud; John R Walker; Ana-Mirela Neculai; Dante Neculai; Andrew Vorobyov; Pankaj Garg; Linda Beatty; Pak-Kei Chan; Yu-Chi Juang; Marie-Claude Landry; Christina Yeh; Elton Zeqiraj; Konstantina Karamboulas; Abdellah Allali-Hassani; Masoud Vedadi; Mike Tyers; Jason Moffat; Frank Sicheri; Laurence Pelletier; Daniel Durocher; Brian Raught; Daniela Rotin; Jianhua Yang; Michael F Moran; Sirano Dhe-Paganon; Sachdev S Sidhu
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

8.  Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor.

Authors:  A G Batzer; D Rotin; J M Ureña; E Y Skolnik; J Schlessinger
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

9.  Super-SILAC allows classification of diffuse large B-cell lymphoma subtypes by their protein expression profiles.

Authors:  Sally J Deeb; Rochelle C J D'Souza; Jürgen Cox; Marc Schmidt-Supprian; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2012-03-21       Impact factor: 5.911

10.  Activation of p38 mitogen-activated protein kinase promotes epidermal growth factor receptor internalization.

Authors:  Silvia Vergarajauregui; Anitza San Miguel; Rosa Puertollano
Journal:  Traffic       Date:  2006-06       Impact factor: 6.215

View more
  46 in total

1.  Deep transcriptome annotation enables the discovery and functional characterization of cryptic small proteins.

Authors:  Sondos Samandi; Annie V Roy; Vivian Delcourt; Jean-François Lucier; Jules Gagnon; Maxime C Beaudoin; Benoît Vanderperre; Marc-André Breton; Julie Motard; Jean-François Jacques; Mylène Brunelle; Isabelle Gagnon-Arsenault; Isabelle Fournier; Aida Ouangraoua; Darel J Hunting; Alan A Cohen; Christian R Landry; Michelle S Scott; Xavier Roucou
Journal:  Elife       Date:  2017-10-30       Impact factor: 8.140

2.  Sulfiredoxin Promotes Colorectal Cancer Cell Invasion and Metastasis through a Novel Mechanism of Enhancing EGFR Signaling.

Authors:  Hong Jiang; Lisha Wu; Jing Chen; Murli Mishra; Hedy A Chawsheen; Haining Zhu; Qiou Wei
Journal:  Mol Cancer Res       Date:  2015-08-19       Impact factor: 5.852

3.  A Cross-Linking-Aided Immunoprecipitation/Mass Spectrometry Workflow Reveals Extensive Intracellular Trafficking in Time-Resolved, Signal-Dependent Epidermal Growth Factor Receptor Proteome.

Authors:  Yue Chen; Mei Leng; Yankun Gao; Dongdong Zhan; Jong Min Choi; Lei Song; Kai Li; Xia Xia; Chunchao Zhang; Mingwei Liu; Shuhui Ji; Antrix Jain; Alexander B Saltzman; Anna Malovannaya; Jun Qin; Sung Yun Jung; Yi Wang
Journal:  J Proteome Res       Date:  2019-09-09       Impact factor: 4.466

4.  Differential regulation of FGFR3 by PTPN1 and PTPN2.

Authors:  Jonathan R St-Germain; Paul Taylor; Wen Zhang; Zhihua Li; Troy Ketela; Jason Moffat; Benjamin G Neel; Suzanne Trudel; Michael F Moran
Journal:  Proteomics       Date:  2014-12-17       Impact factor: 3.984

5.  Deficiency in the secreted protein Semaphorin3d causes abnormal parathyroid development in mice.

Authors:  Anamika Singh; Masum M Mia; Dasan Mary Cibi; Ashutosh Kumar Arya; Sanjay Kumar Bhadada; Manvendra K Singh
Journal:  J Biol Chem       Date:  2019-04-12       Impact factor: 5.157

6.  Identification of human plasma cells with a lamprey monoclonal antibody.

Authors:  Cuiling Yu; Yanling Liu; Justin Tze Ho Chan; Jiefei Tong; Zhihua Li; Mengyao Shi; Dariush Davani; Marion Parsons; Srijit Khan; Wei Zhan; Shuya Kyu; Eyal Grunebaum; Paolo Campisi; Evan J Propst; David L Jaye; Suzanne Trudel; Michael F Moran; Mario Ostrowski; Brantley R Herrin; F Eun-Hyung Lee; Ignacio Sanz; Max D Cooper; Götz Ra Ehrhardt
Journal:  JCI Insight       Date:  2016-03-17

Review 7.  Advances in targeted proteomics and applications to biomedical research.

Authors:  Tujin Shi; Ehwang Song; Song Nie; Karin D Rodland; Tao Liu; Wei-Jun Qian; Richard D Smith
Journal:  Proteomics       Date:  2016-08       Impact factor: 3.984

8.  Regulation of autoimmune disease by the E3 ubiquitin ligase Itch.

Authors:  Emily K Moser; Paula M Oliver
Journal:  Cell Immunol       Date:  2019-04-05       Impact factor: 4.868

9.  Rational combination with PDK1 inhibition overcomes cetuximab resistance in head and neck squamous cell carcinoma.

Authors:  Haiquan Lu; Yang Lu; Yangyiran Xie; Songbo Qiu; Xinqun Li; Zhen Fan
Journal:  JCI Insight       Date:  2019-10-03

10.  Ligand-activated epidermal growth factor receptor (EGFR) signaling governs endocytic trafficking of unliganded receptor monomers by non-canonical phosphorylation.

Authors:  Tomohiro Tanaka; Yue Zhou; Tatsuhiko Ozawa; Ryuya Okizono; Ayako Banba; Tomohiro Yamamura; Eiji Oga; Atsushi Muraguchi; Hiroaki Sakurai
Journal:  J Biol Chem       Date:  2017-12-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.